Johnson & Johnson (JNJ) Q3 2026 Earnings Call Transcript | EN590 Commodities

Market Analysis 2026-10-13T16:42:46-04:00

Johnson & Johnson (JNJ) Q3 2026 Earnings Call October 13, 2026 8:30 AM EDT Ryan Koors - Vice President of Investor RelationsJoaquin Duato - CEO & ChairmanJoseph Wolk - Executive VP & CFOTim Schmid - Executive VP & Worldwide Chairman of MedTechTom Cavanaugh - Executive VP & Worldwide Chairman of Innovative MedicineJohn Reed - Executive Vice President of Innovative Medicine and R&D Asad Haider - Goldman Sachs Group, Inc., Research DivisionLarry Biegelsen - Wells Fargo Securities, LLC, Research DivisionChristopher Schott - JPMorgan Chase & Co, Research DivisionJoanne Wuensch - Citigroup Inc., Research DivisionRichard Wagner - BofA Securities, Research DivisionVamil Divan - Guggenheim Securities, LLC, Research DivisionMichael Yee - UBS Investment Bank, Research DivisionJayson Bedford - Raymond

About EN590 Commodities Group

25+ years in mineral exploration and extraction. 15+ years of global commodity trading. Based in New York, USA serving 75+ countries.

Join our Telegram channel: t.me/EN590

Visit our Blog